Showing results (221-230 of 430) with videos related to
Sort By:
Pageof 43
Odonto-Stomatologie Tropicale = Tropical Dental Journal|October 19, 2011
Frequency, causes and pattern of adult tooth extraction in a Nigerian rural health facilityO E Danielson, A C Chinedu, E A Oluyemisi, et al.Journal of Neuroscience Research|February 6, 1998
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous systemE A Thomas, B F Cravatt, P E Danielson, et al.Journal of the California Dental Association|October 24, 2001
Controlling biofilm and microbial contamination in dental unit waterlinesT K Lee, E J Waked, L E Wolinsky, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Vitamin D receptor gene polymorphisms, bone turnover, and rates of bone loss in older African-American womenJ M Zmuda, J A Cauley, M E Danielson, et al.British Journal of Clinical Pharmacology|April 12, 2001
Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placementH A Walker, G Jackson, J M Ritter, et al.JAMA|September 10, 1982
Hypernatremia induced by maximal exerciseP Felig, C Johnson, M Levitt, et al.Cancer|April 1, 1975
Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapyD Berd, J Cornog, R C DeConti, et al.European Journal of Immunology|April 12, 2001
Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I moleculesJ M Levitt, D D Howell, J R Rodgers, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.Molecular Cancer Therapeutics|April 22, 2010
Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signalingJonathan M Levitt, Hideyuki Yamashita, Weiguo Jian, et al.Pageof 43